ANKARA – Phase-three trials began on Monday of a candidate vaccine against the novel coronavirus in the US, with an expected enrollment of 30,000 volunteers,
ANKARA – Phase-three trials began on Monday of a candidate vaccine against the novel coronavirus in the US, with an expected enrollment of 30,000 volunteers,